The TST involves the intradermal injection of purified protein derivative (PPD) tuberculin into the skin, usually on the forearm. After 48 to 72 hours, the injection site is examined for induration (hardened swelling). The size of the induration is measured in millimeters, and the result helps determine whether a person has been exposed to TB bacteria.